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Overuse tendon injuries are a major cause of musculoskeletal morbidity in both
human and equine athletes, due to the cumulative degenerative damage. These
injuries present significant challenges as the healing process often results in the
formation of inferior scar tissue. The poor success with conventional therapy supports
the need to search for novel treatments to restore functionality and regenerate
tissue as close to native tendon as possible. Mesenchymal stem cell (MSC)-based
strategies represent promising therapeutic tools for tendon repair in both human and
veterinary medicine. The translation of tissue engineering strategies from basic research
findings, however, into clinical use has been hampered by the limited understanding
of the multifaceted MSC mechanisms of action. In vitro models serve as important
biological tools to study cell behavior, bypassing the confounding factors associated
with in vivo experiments. Controllable and reproducible in vitro conditions should be
provided to study the MSC healing mechanisms in tendon injuries. Unfortunately, no
physiologically representative tendinopathy models exist to date. A major shortcoming
of most currently available in vitro tendon models is the lack of extracellular tendon
matrix and vascular supply. These models often make use of synthetic biomaterials,
which do not reflect the natural tendon composition. Alternatively, decellularized
tendon has been applied, but it is challenging to obtain reproducible results due
to its variable composition, less efficient cell seeding approaches and lack of cell
encapsulation and vascularization. The current review will overview pros and cons
associated with the use of different biomaterials and technologies enabling scaffold
production. In addition, the characteristics of the ideal, state-of-the-art tendinopathy
model will be discussed. Briefly, a representative in vitro tendinopathy model should be
vascularized and mimic the hierarchical structure of the tendon matrix with elongated
cells being organized in a parallel fashion and subjected to uniaxial stretching.
Incorporation of mechanical stimulation, preferably uniaxial stretching may be a key
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element in order to obtain appropriate matrix alignment and create a pathophysiological
model. Together, a thorough discussion on the current status and future directions
for tendon models will enhance fundamental MSC research, accelerating translation
of MSC therapies for tendon injuries from bench to bedside.
Keywords: tendinopathy, biomaterials, tendon, in vitro tendon models, bioreactors
INTRODUCTION
Tendon overuse injuries are one of the most common sports-
related injuries both in humans and horses (Carpenter and
Hankenson, 2004). The Achilles tendon in human patients
and the superficial digital flexor tendon (SDFT) in equine
patients are frequently injured structures due to their capacity
to store energy during high-speed locomotion. The cumulative
degenerative damage to tendons caused by high-intensity exercise
and age-related microdamage might result in chronic problems
of tendinopathy. Currently, injuries to the equine SDFT is the
most appropriate animal model for human Achilles tendon
injuries (Patterson-Kane et al., 2012; Burk et al., 2013a).
Besides the chronic pain and early retirement in equine and
human athletes, tendinopathy also causes economic losses and
animal welfare concerns (Patterson-Kane et al., 2012). Tendons
are hierarchically organized based on a triple-helix of cross-
linked tropocollagen, forming insoluble collagen molecules
which aggregate progressively into microfibrils, fibrils, and fibers
(Figure 1). Different fibers are combined into a bundle, called
“fascicles”, surrounded by endotenon. In their turn, different
fascicles are grouped and surrounded by epitenon. Both endo-
and epitenon supply the tendon with blood vessels, nerves
and lymphatics (Wang, 2006; Docheva et al., 2015; Tan et al.,
2015; Schneider et al., 2018). Tendon extracellular matrix (ECM)
consists physiologically mainly of collagen I (95%), while collagen
III is present in the endotenon (1–3%) (Spaas et al., 2012; Tan
et al., 2015). In addition to collagen, elastin renders the tendon
tissue flexible and extensible, while the ground substance in
the ECM is essential for proper metabolism, shock absorption,
viscoelasticity, and support (Schneider et al., 2018). Important
components of the latter include proteoglycans (e.g., decorin
and lumican) and glycoproteins (e.g., tenascin-C, tenomodulin,
and cartilage oligomeric matrix protein). Scleraxis and Mohawk
are major tenocyte-specific transcription factors which support
matrix production, tenocyte proliferation, and differentiation
(Liu et al., 2015). The cellular compartment of tendons consists of
specialized fibroblasts, i.e., tenocytes and tenoblasts, and recently
identified tendon stem/progenitor cells (Bi et al., 2007; Wang
et al., 2017; Costa-Almeida et al., 2018b; Sensini and Cristofolini,
2018; Zhang et al., 2020).
Abbreviations: 2D, two-dimensional; 3D, three-dimensional; AT-MSC(s),
adipose tissue-derived mesenchymal stem cell(s); BM-MSC(s), bone marrow-
derived mesenchymal stem cell(s); dECM, decellularized extracellular matrix;
ECM, extracellular matrix; ELAC, electrochemically aligned collagen; HUVEC(s),
human umbilical vein endothelial cell(s); MSC(s), mesenchymal stem cell(s); PCL,
poly-ε-caprolactone; PDMS, polydimethylsiloxane; PGA, polyglycolic acid; PLA,
polylactic acid; PLGA, polylactide-co-glycolide; SDFT, superficial digital flexor
tendon; UTS, ultimate tensile strength; VEGF, vascular endothelial growth factor.
Immediately following acute tendon damage, an inflammatory
phase is observed, in which various inflammatory and
immune cells are attracted to the injury site. Subsequently,
the proliferation phase starts, characterized by fibroplasia,
angiogenesis and new ECM synthesis. Finally, during the
remodeling or maturation phase, tendon fibers are realigned
and scar tissue is replaced by tissue-specific cells and matrix
to restore native tissue properties (Spaas et al., 2012). In adult
tendons, however, the healing process results in the presence of
inferior scar tissue lacking the structural integrity and elasticity
of the original tendon (Evans, 2012; Spaas et al., 2012; Docheva
et al., 2015; Adekanmbi et al., 2017; Schneider et al., 2018;
Sensini and Cristofolini, 2018; Costa-Almeida et al., 2019;
Khatibzadeh et al., 2019). The limited functionality of healed
tendon tissue represents a high risk of reduced performance
and/or reinjury (Dyson, 2004; Spaas et al., 2012). To date, we
lack knowledge on the molecular and cellular basis of tendon
physiology and fail to capture essential aspects of its pathology
(Nichols et al., 2019; Wunderli et al., 2020), particularly during
the early stages of injury (Dakin et al., 2012). Hypocellularity
and hypovascularization of the tendon may affect its ability
to respond to inflammation and reduce its efficacy to repair
injured tissue (Dakin et al., 2012; Nichols et al., 2019). Indeed,
neovascularization occurs in response to hypoxia-associated
vascular endothelial growth factor (VEGF) secretion. However,
these neovessels are not completely functional and fail to deliver
properly nutrients and oxygen. Consequently, the persistent
hypoxia aggravates inflammation and MMP secretion, which
results in further disruption of the tendon (Chung and Shum-
Tim, 2012; Costa et al., 2007). Current tendinopathy treatments
in humans and horses include physical therapies (cold, pressure,
support, shock wave therapy, and rehabilitation programs),
drug treatments (systemic or intra-lesional anti-inflammatory
medication) and surgery (tenoscopy and tendon splitting), but
all these therapies fail to provide tendon regeneration and restore
the functionality of the original tendon tissue (Smith, 2008;
Docheva et al., 2015; Ramos et al., 2019). The poor success of
conventional therapy supported the need to search for novel
treatments to regenerate a tissue mimicking the tendon to the
greatest extent as possible (Richardson et al., 2007). Despite the
great interest in MSCs due to their ability to repair tissue and
reduce inflammation (Sevivas et al., 2018), common clinical
applications have been hampered by several limitations. First,
many experimental and pre-clinical studies have been evaluating
the regenerative potential of MSCs for tendon healing and
although clinical translation appears temptingly close (Pacini
et al., 2007; Nixon et al., 2008; Schnabel et al., 2009; Godwin
et al., 2012; Ricco et al., 2013; Smith et al., 2013; Van Loon et al.,
2014), convincing evidence based on randomized, controlled,
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clinical studies in equine or human patients, is still lacking
(Pas et al., 2017; Phelps et al., 2018; Khatibzadeh et al., 2019)
and outcomes of long-term follow-up studies do not meet
expectations (Geburek et al., 2017; Ahrberg et al., 2018). Second,
various practical considerations regarding MSC source, dosage,
administration technique, and timing, remain unanswered
(Costa-Almeida et al., 2019; Shojaee and Parham, 2019). It
is known that MSCs isolated from different sources display
significantly diverse properties indicating potential advantages
and disadvantages for the use of each MSC type in particular
clinical applications (Burk et al., 2013b; Harman et al., 2020).
Bone marrow, adipose tissue, and peripheral blood are the
most commonly used MSC sources in equine regenerative
medicine. Although adipose tissue-derived MSCs (AT-MSCs)
are more easily accessible and have a higher yield after harvesting
compared to bone marrow-derived MSCs (BM-MSCs), better
results in treating tendon injuries are obtained with the latter
(Dai et al., 2015; Zarychta-Wisniewska et al., 2019). MSCs
isolated from neonatal sources, however, are reported to have a
longer lifespan than MSCs isolated from adult tissues, secrete
more extracellular vesicles, and show broader differentiation
capacity (Burk et al., 2013b; Iacono et al., 2017; Gugjoo et al.,
2019). Moreover, it has been reported that the regenerative
capacity of aged cells can be restored when exposed to a young
environment. These findings suggest opportunities to reverse
the aging process of tissues by targeting their niche (Lui and
Wong, 2020). As such, MSC-based strategies isolated from
neonatal sources might represent promising therapeutic tools
for tendon repair and regeneration (Sevivas et al., 2018). Third,
most in vitro studies investigate tenogenic differentiation of
MSCs while some studies explored the interaction between
MSCs and tenocytes, MSCs and tendon ECM or the effects of
their secretome products, but their underlying mechanisms of
action have been rarely studied (Liu et al., 2017; Burk, 2019).
A decade ago, Dirks and Warden reviewed the models available
to study tendinopathy and concluded that a wide range of models
(in vitro, ex vivo and in vivo models) is mandatory to completely
understand the pathogenesis of tendinopathy. To gain insight
in the underlying molecular pathways, however, in vitro models
serve as important biological tools to study cell behavior under
controlled conditions, bypassing the confounding factors
associated with in vivo clinical trials (Dirks and Warden, 2011).
Nowadays, a wide diversity of in vitro tendon models are
used to improve our fundamental understanding of tendon
mechanobiology and to study tissue replacement processes,
cell-based treatments, and drug screening applications, but no
generally accepted in vitro model exists (Butler et al., 2008;
Patterson-Kane et al., 2012; Patel et al., 2017; Wang et al., 2017;
Laternser et al., 2018). To the best of our knowledge, both in
humans and (laboratory) animals, a generally accepted in vitro
tendinopathy model is not available yet.
Initially, the use of MSCs for primary tissue regeneration
was advocated based on their ability to migrate to and
engraft in the injury site, where they would differentiate into
various appropriate cell types. Nowadays, however, MSCs are
considered “medicinal cell factories” secreting a variety of
bioactive molecules, either in soluble form or via extracellular
vesicles, with immunomodulatory, ECM modeling, trophic and
anti-apoptotic activities, collectively identified as the secretome
(da Silva Meirelles et al., 2009; Manning et al., 2015; Presen
et al., 2019; Zhang et al., 2020). Indeed, MSC-conditioned
medium (MSC-CM), which includes all their secretome products,
has similar regenerative effects as MSCs, which illustrates the
impact of these secretome products (Phelps et al., 2018). It
has also been demonstrated in vitro that cell proliferation and
migration of injured tenocytes were promoted after MSC-CM
administration (Chen et al., 2018; Li et al., 2020). Nevertheless,
the regenerative capacities of MSCs are multifaceted and strongly
cell- and tissue context-dependent, and the insights into their
trophic and protective mechanisms in the context of tendon
therapies remain scarce (Pas et al., 2017; Vizoso et al., 2017;
Bogatcheva and Coleman, 2019; Burk, 2019; Harrell et al., 2019;
Presen et al., 2019; Al Naem et al., 2020). As there is an urgent
need to (i) unravel the MSCs’ mechanisms of action, (ii) find a
therapy that consistently yields positive results, (iii) investigate
the most optimal treatment protocol, (iv) unravel the wide
potential of the MSCs’ bioactive factors, and (v) identify the most
appropriate MSC source, an optimal in vitro tendon model might
provide a lot of answers. Moreover, by establishing a state-of-the-
art physiologically representative in vitro tendinopathy model,
the use of experimental animals will be drastically reduced.
The effect of potential therapies for tendinopathy, with great
emphasis on MSCs and their secretome, can be studied in vitro,
and answers to questions relevant for clinical applications (like
timing of treatment, dosage, immunomodulatory activities, etc.)
can be provided, further reducing the number of in vivo
experiments considerably.
An overview of the models available to mimic tendon
tissue in vitro with increasing complexity is given throughout
the review (Figure 2). Elements to establish a representative
in vitro tendinopathy model are suggested, including techniques
which might be promising but are not yet optimized to
incorporate in a tendon model. Rather than citing all available
literature on tendon tissue engineering, models are discussed
with an emphasis on their strengths and shortcomings regarding
fundamental research on the regenerative capacities of MSCs.
Therefore, the evaluation criteria incorporated in this review
are i) representative cellular phenotype (of tenocytes, tenogenic-
differentiated MSCs, fibroblasts, or tendon stem/progenitor cells)
as demonstrated by the spindle-shape morphology and tenocyte
marker expression, (ii) production of ECM (evaluated by gene
expression and immunohistochemistry) and allowing cell–matrix
interactions, (iii) supporting nanometric and axially aligned
structure (anisotropy), (iv) responsive to physiological levels of
uniaxial strain, (v) neuro-vascular supply, and (vi) mimicking




2D cell cultures are commonly used to study cell behavior. In such
a simplified environment, basic morphology, gene expression,
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FIGURE 1 | Schematic illustration of the hierarchical structure of tendons.
Adjusted from Durgam and Stewart (2016) and ChemBAM (n.d.).
and differentiation are easily studied without confounding
factors (Laternser et al., 2018). However, mimicking the
biomechanical and -chemical environment of native tendon
is crucial when studying the behavior and mechanisms of
action of MSCs (Grier et al., 2017; Al Naem et al., 2020).
A common issue in 2D tenocyte cultures is dedifferentiation.
With increasing cell passage, tenocytes lose their characteristic
spindle-like morphology and consequently, their functionality
(Yao et al., 2006). Their changing morphology is accompanied
by a significant decrease in collagen I and tenomodulin
mRNA expression, as demonstrated in the study of Zhu
et al. (Zhu et al., 2010). Unlike in vitro cultured tenocytes,
tenocytes in vivo are not organized in confluent sheets and
are able to actively interact with the ECM (Patterson-Kane
et al., 2012; Laternser et al., 2018). Therefore, 2D cultures
are no longer used for tissue functionality or regeneration
studies. However, these models are still useful for setting up
preliminary experiments, implementation as control condition
or, for example, investigating cytotoxic effects (Occhetta et al.,
2013; Fessel et al., 2014). Because of their simplicity, 2D
models are more cost-effective than the sophisticated techniques
explained below (Figure 3) (Wunderli et al., 2020).
2D Models Combined With Mechanical
Stimulation and/or Surface Topography
Contact-guidance might offer a solution to maintain tenocyte
differentiation in 2D cell cultures. Mechanical stimulation
and surface topography of cell culture surfaces influence cell
density, cellular alignment, and the organization of newly
deposited matrix (Nikolovski et al., 2003; Park et al., 2006;
Zhang et al., 2021; Kuo et al., 2010). In vivo, it is known
that mechanical stimulation is important to maintain tendon
homeostasis (Screen et al., 2005). However, cultured cells
in vitro also respond to mechanical strain by displaying a more
spindle-shaped morphology and adjusting their DNA synthesis
toward the production of collagen I (Figure 3) (Wang et al.,
2003; Matheson et al., 2006). As such, Riboh et al. (2008)
induced the tenogenic phenotype in epitenon tenocytes, sheath
fibroblasts, bone BM-MSCs and AT-MSCs by exposing the
cells to intermittent cyclic strains (4%, 0.1 Hz, 1 h on/2 h
off). To study the impact of surface topography on cellular
alignment and tenocyte characteristics, Kapoor et al. (2010)
used grooved substrates with different diameters (50–250 µm)
to verify the influence of physical parameters on tenocytes.
Both cell density and cellular alignment were affected by
the microtopography of the substrates, with 50 µm grooves
having the most pronounced impact, as demonstrated by
denser and more longitudinally oriented collagen fibers. No
significant impact was observed on matrix gene expression
or cell phenotype (Kapoor et al., 2010). However, when
micro-grooved silicone surfaces were combined with cyclic
uniaxial stretching, human tenocytes showed a phenotype
comparable to the in vivo situation and an increased cellular
production of collagen type I in a stretching-magnitude-
dependent manner (4 and 8% stretch) (Wang et al., 2003;
Yang et al., 2004). Despite the improved knowledge on cell
proliferation and cellular alignment, these modified 2D cell
cultures still lack structural complexity to mimic tendinopathy
in vitro.
Three-Dimensional (3D) Models
Apart from contact-guidance, tenocyte dedifferentiation can also
be countered by spheroid formation. As such, a 3D set-up was
developed using hanging drop cultures, in which tenocytes are
exposed to microgravity (Theiss et al., 2015). Theiss et al. (2015)
and Kraus et al. (2017) generated equine tenocyte spheroids
when specific growth factors were supplemented to the culture
medium. They observed that tenocytes within spheroids better
preserved their spindle-like morphology and showed enhanced
expression of tenogenic genes like collagen I, collagen III, and
scleraxis and expression of the chondrogenic transcription factor
SOX9 (Theiss et al., 2015; Kraus et al., 2017). Spheroids provide
the functionality which is lacking in 2D cultures, and as such,
are more suitable to study pathological conditions in vitro
(Figure 3) (Laternser et al., 2018). Calve et al. (2004) were
the first to engineer viable tendon tissue constructs in vitro
without using artificial scaffolds. They created these constructs by
allowing self-assembly of isolated rat Achilles tendon tenocytes
into a cylinder, which resembled embryonic tendon consisting
of collagen fibrils, many tenocytes and a non-collagenous ECM.
Moistening of the constructs was provided by bathing each
sample individually in culture medium. Both for spheroids
and the self-assembled tenocyte cylinders, cell–cell and cell–
matrix interactions can be studied as the cultured tenocytes
produce ECM. Therefore, to extrapolate in vitro results to
in vivo clinical trials, it would be of great benefit to study
MSCs in 3D environments (Burk, 2019), as for example the
immunomodulatory potential of the MSCs is shown to be
altered in 3D vs. 2D (Follin et al., 2016; Li et al., 2018). The
disadvantages of these techniques are the small model size and
the low mechanical properties of the constructs when compared
to mature tendons due to the rather immature morphology of
the tenocytes and the lack of mechanical stimulation during the
culture period (Calve et al., 2004).
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FIGURE 2 | Illustration of the review’ structure, starting from very basic but very unclear, blurred models to increasingly complex models, which are more appropriate
to represent an injured Achilles tendon and to clarify the MSC mechanisms of action.
Explant Models
Another approach to study tendon tissue is by using tendon
explant models. Intact native tissue samples can be dissected and
cultured ex vivo. The main advantage of this method is the intact
tissue architecture, which allows studying cell-ECM interactions
in a near-physiological environment. These models have been
used for structure and function characterization of tendon tissue,
to study cell-mediated processes and to investigate crosstalk
mechanisms (Wunderli et al., 2020). “Clamp and stretch” models
of these explants are often implemented to define mechanical
characteristics of tendon tissue (Goldstein et al., 1987). This
technique is characterized by the application of mechanical
load in a longitudinal manner on a tissue sample clamped
at both ends, while the deformation and applied forces are
monitored (Dyment et al., 2020). Many different bioreactors
have been developed for mechanical stimulation of cell and
tissue cultures, which are described in more detail in the section
“Advanced: Incorporating bioreactors”. The most frequently
described problems of longitudinal stretch systems are the rather
heterogeneously transmitted strain, along with grip slippage due
to the high mechanical forces used (Figure 3) (Brown, 2000).
Basic “clamp and stretch” studies often cover a small-time interval
because of the lack of nutrient supplementation, resulting in
dry, non-physiological circumstances. Devkota and Weinhold
(2005) developed an advanced tissue explant system to create
and monitor mechanical changes occurring with tendon overuse.
The machine can be placed in a standard incubator and is
equipped with video strain analysis capabilities for monitoring.
Another improvement over previous models is the use of load-
controlled operation, preventing grip slippage (Devkota and
Weinhold, 2005). The incorporation of mechanical stimulation
mimics the in vivo load-bearing function. Explant models as
such can provide useful insight into tendon (patho-)physiology
and have also previously been used to study MSC characteristics.
Costa-Almeida et al. (2018a) studied the communication between
AT-MSCs and native tendon ECM in a trans-well tendon
explant model. Although the AT-MSCs were not directly in
contact with the tendon explant, significant changes in MMP
secretion, collagen III and tenascin-C deposition were monitored
when AT-MSC were co-cultured compared to single tenocyte
cultures, suggesting ECM remodeling. The authors proposed
explant co-cultures as a tool to unravel cellular communication
and tendon healing (Costa-Almeida et al., 2018a). Wunderli
et al. (2020) excessively reviewed tendon explant models for
physiologically relevant in vitro studies and confirmed their
suitability for investigating cellular cross-talk. Furthermore,
Youngstrom et al. (2015) reseeded decellularized tendon scaffolds
with BM-MSCs to evaluate the effects of different strain
protocols on ECM composition, gene expression and mechanical
properties of the scaffolds. The goal of these experiments,
however, was to validate the custom-designed bioreactor and
not specifically to characterize MSCs (Youngstrom et al., 2015).
Nevertheless, explant models are subjected to variable conditions
which are not controllable enough to obtain reproducible results
when aiming to elucidate exact MSCs’ mechanisms of action
(Wunderli et al., 2020).
BEGINNER: MODELS USING
BIOMATERIALS
Biomaterials are defined as any material that is able to interact
with biological systems and can consist of natural and/or
synthetic materials (National Institute of Biomedical Imaging
and Bioengineering, n.d.). While standard cell culture materials
do not resemble physiological circumstances, e.g., native ECM,
biomaterials are specifically designed to deliver mechanical,
structural, and compositional stimuli to the cells (Caliari and
Burdick, 2016). Most requirements for biomaterials are based
on demands for tissue engineering. In relation to an in vitro
tendon model these include (i) correct biochemical composition
and structure, (ii) biocompatibility toward appropriate cell
population, (iii) appropriate mechanical strength and elasticity
to mimic cell-microenvironment interactions of in vivo tendon
tissue, and (iv) an easily processable material (Ma, 2004; Kuo
et al., 2010; Rodrigues et al., 2013). An overview of the advantages
and disadvantages of the discussed materials is given in Figure 4.
Natural Materials
Currently used natural materials for tendon applications are
hyaluronic acid, silk fibroin, collagen and gelatin. The general
advantage of using natural materials for tissue engineering
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FIGURE 3 | Advantages and disadvantages of basic tendinopathy models without scaffolds. Adjusted from Krishna et al. (2016); Ryu et al. (2019) and Tohidnezhad
et al. (2020).
FIGURE 4 | Advantages and disadvantages of tendinopathy models incorporating biomaterials. Adjusted from Barrett et al. (2013) and ChemBAM (n.d.).
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is the good cytocompatibility due to the functional chemical
groups available for cellular binding. For example, the tripeptide
arginine-glycine-aspartic acid (RGD) sequence functions as
integrin-binding sites, which are of critical importance for cell
adhesion (Ruoslahti, 1996). For tissue engineering, it is important
that cells delivered through the scaffold remain in place, but also
for an in vitro model, it is of great importance that cultured cells
can interact with the biomaterial.
Collagen I is the most extensively used natural material
because of its low cost and high physiological prevalence in
tendon tissue (Kuo et al., 2010; Caliari and Burdick, 2016; Wu
et al., 2018). Although collagen gels, sponges and extruded
fibers are being used for tendon tissue engineering, their main
drawback is mechanical weakness (Qiu et al., 2016; Lake et al.,
2020). Cheng et al. (2008) were able to upregulate the mechanical
strength of collagen (30-fold) by producing electrochemically
aligned collagen (ELAC) bundles. When these bundles were
seeded with MSCs, the expression of tendon-specific genes
(scleraxis and tenomodulin) was upregulated when compared
to randomly oriented collagen threads, which illustrates that
collagen might be used to replace tendon (Kishore et al., 2012;
Shimada et al., 2014). As with all natural materials, another
disadvantage of extracted collagen is batch-to-batch variability,
which can be circumvented by using recombinant collagen
(Slaughter et al., 2009; Tytgat et al., 2019). Gelatin is denatured
collagen which can be used as an ECM mimic after chemical
modification and crosslinking to provide stability at elevated
temperatures and which is less immunogenic when compared
to collagen (Laternser et al., 2018; Van Hoorick et al., 2019).
Other advantages are low cost and wide availability, especially
when considering large-scale in vitro studies (Van Hoorick et al.,
2019). Furthermore, we recently demonstrated the excellent
biocompatibility of cross-linked gelatin (gelatin-methacrylamide
and gelatin-norbornene) to support equine tenocyte cultures
(Meeremans et al., 2021). Silk fibroin is a worthy alternative to
collagen and gelatin for tendon and ligament tissue engineering
and is collected from silkworms, mostly Bombyx mori. The
advantages of silk are its strong mechanical characteristics,
good cytocompatibility, easy processability, and its potential to
be changed into many different forms (Minoura et al., 1995;
Rockwood et al., 2011; Yao et al., 2016). In the study of
Chen et al. (2010), knitted silk-collagen scaffolds were used in
which seeded MSCs showed good adherence to the scaffold,
proliferated well, and showed tendon biocompatibility after
mechanical stimulation. Tenogenic differentiation of MSCs,
characterized by adopting a tenocyte-like shape and expression
of tendon-related genes, illustrates the suitability of silk for
supporting tenocyte cultures and tendon tissue engineering.
Hyaluronic acid belongs to the group of glycosaminoglycans and
is often implemented in tendon tissue engineering to increase
the mechanical strength (Liu Y. et al., 2008). Funakoshi et al.
(2005) fabricated a 3D chitosan/hyaluronic acid scaffold to repair
tendon defects in an in vivo rabbit model. This newly designed
scaffold had previously shown potential as a biomaterial for
cartilaginous tissue scaffolds and was, therefore, hypothesized
to enhance collagen I production when implanted in in vivo
tendon defects. This study found that in addition to the enhanced
collagen production, the mechanical strength of the regenerated
tendons also increased when seeded with fibroblasts, displaying
potential for an in vitro tendon culture (Funakoshi et al., 2005;
Yamane et al., 2005).
Synthetic Materials
Synthetic materials are also widely used in tissue engineering as
they provide excellent mechanical support, are easily processable,
and are cost-effective. Synthetic polymers applied in tendon
tissue engineering are e.g., polylactic acid (PLA), polyglycolic acid
(PGA), and their copolymers such as polylactide-co-glycolide
(PLGA) (Ouyang et al., 2003; Cao et al., 2006; Chen et al.,
2010; Yang et al., 2016; Aldana and Abraham, 2017; Wu et al.,
2018). All belong to the group of polyesters and are attractive
for in vivo use due to the formation of natural metabolites
upon degradation. However, because of the hydrophobic nature
of polyesters, cell adhesion is far from optimal and their
in vitro application is less attractive (Liu Y. et al., 2008).
Cao et al. (2006) were able to generate tendon tissue in vitro
by culturing tenocytes on PGA fibers arranged into a cord-
like construct, both with and without application of constant
strain (two groups). They found that the generated tissue
resembled natural tendon tissue histologically in both groups,
as opposed to the cell-free control group. The application of
constant strain improved mechanical characteristics but was
detrimental for scaffold thickness and collagen fiber alignment,
and thus, considered suboptimal. The authors suggested that
aligned fibers instead of non-woven fibers should be used
preferably and that the strain regime for mechanical load
should be intermittent instead of constant (Cao et al., 2006).
The fact that polymer fibers should be aligned to mimic the
highly organized collagen fibers, was further corroborated by
a study of Lee et al. (2005), where they developed tissue-
engineered ligaments of polyurethane. Tendons and ligaments
indeed have some features in common such as the hierarchical
structure and the non-linear mechanical properties (Sensini
and Cristofolini, 2018). Moreover, when aligned PLA scaffolds
were used, Yin et al. (2010) showed that tendon stem cells
displayed a spindle-shape morphology and tendon-like tissue
was formed. Ouyang et al. (2003) and Sahoo et al. (2006)
compared different PLGA production technologies to create a
tendon/ligament biodegradable scaffold. Both in vivo and in vitro
studies described favorable BM-MSC morphology (spindle-
shape) and alignment (Ouyang et al., 2003; Sahoo et al., 2006).
Synthetic polymers are often implemented for their superior
mechanical strength but they lack functional chemical groups
for cellular binding and often need surface modification (Kuo
et al., 2010). Locke et al. (2020) recently assessed the use
of synthetic polyethylene glycol (PEG) hydrogels. To create a
material suitable for tendon regeneration, a degradable linker
peptide, a multifunctional collagen mimetic peptide and integrin-
binding peptide sequences were incorporated into the hydrogel
(Locke et al., 2020). Although the authors highlighted the
potential of such multifunctional and synthetic hydrogels for
tissue regeneration, especially when considering their mechanical
properties, the approach is rather complex to (repeatedly)
implement in an in vitro model.
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Hybrids
An in vitro tendon model needs comparable mechanical
strength as natural tendon to mimic the physiological stiffness
the cells experience in vivo, but also specific surface stimuli
for cell proliferation, hybrids are preferred for tendon tissue
engineering. Hybrid scaffolds consist of various synergistically
combined natural and synthetic polymers (Kuo et al., 2010).
As previously mentioned, a knitted collagen-silk scaffold was
suitable for tenogenic differentiation of human MSCs, but no
comparison with other scaffolds was made in that particular
study (Chen et al., 2010). Liu H. et al. (2008) seeded a combined
scaffold of knitted silk and microporous silk sponge with BM-
MSCs for (anterior cruciate) ligament tissue engineering and
successfully overcame limitations of individual designs. Poly-
ε-caprolactone (PCL), a synthetic biomaterial is often used in
tissue engineering because of its biocompatibility, low cost and
slow degradation. However, its hydrophobic nature prevents
efficient cell attachment and the use as mono-material for tendon
tissue engineering or for in vitro model design is, therefore,
not recommended (Yang et al., 2016; Chen et al., 2017). Chen
et al. (2017) combined PCL and silk fibroin in aligned scaffolds
for supporting dermal fibroblast attachment and guidance of
cell proliferation along the orientation of the nanofibers. By
combining both materials, a new superior nanofiber scaffold for
tendon tissue engineering was produced (Chen et al., 2017). Since
the dermal fibroblasts differentiated into tenocytes (Chen et al.,
2017), a similar response is in our opinion to be expected after
tenocyte seeding and thus this strategy is suitable for in vitro
tendon design. A multi-layered PCL/gelatin scaffold for tendon
tissue engineering was designed by the group of Yang. The
scaffolds seeded with AT-MSCs were found to mimic the native
tendon tissue structure, mechanical properties and cell phenotype
(Yang et al., 2016).
Decellularized Constructs
Instead of using polymers and complicated chemical production
technologies, decellularized tendons are also widely used for
tissue engineering (Lake et al., 2020). Decellularization protocols
often use detergents to solubilize cell debris of tendon tissue
samples aiming to remove all immunological signals. These
constructs provide the same mechanical properties and integrin
binding sites as natural tendon tissue, allowing implementation as
a biological graft material in vivo and creating new opportunities
for fundamental research models (Kuo et al., 2010). However,
the amount of removed cells, DNA, immunological signs,
and mechanical characteristics are depending on the used
decellularization process (Kuo et al., 2010; Youngstrom and
Barrett, 2016). When decellularization is combined with chemical
oxidation, mechanical characteristics of the tendon extracts are
preserved and all DNA is withdrawn (Whitlock et al., 2007).
In a study of Youngstrom and Barrett (2016) decellularized
equine SDFT was stated as ideal for tendon tissue engineering
because of the preservation of the biochemical composition,
structure and mechanics of native tendon (Barrett et al.,
2013). Tissue sample decellularization can also be combined
with enzymatic digestion to create soluble decellularized ECM
(dECM), which can be analogously processed like natural and
synthetic materials, or even combined with them (Santschi et al.,
2019). When developing an in vitro model, however, the exact
dECM composition should be determined every time in order
to obtain reproducible results, which results in an undesirably
expensive and cumbersome production process.
INTERMEDIATE: FIBROUS SCAFFOLD
FABRICATION TECHNIQUES
It is important to emphasize different production processes,
as scaffold properties are strongly influenced by the used
processing techniques and applied parameters (Grier et al.,
2017). For example, collagen gels are mechanically very weak,
but their strength can be influenced by different crosslinking
methods. Maximal collagen strength could be reached by physical
crosslinking using dehydrothermal and ultraviolet light, but this
came at the cost of decreased migration of dermal fibroblasts
(Cornwell et al., 2007). Hydrogels, a water-swollen network
of polymers, have emerged as the most promising out of
the different biomaterial systems (Caliari and Burdick, 2016).
The main advantage of hydrogels is their large water content,
mimicking the hydrophilic nature of (tendon) tissue ECM (Yang
et al., 2016; Schneider et al., 2018). A disadvantage is the typically
weak mechanics, which need improvement by various chemical
modifications required for crosslinking.
Important requirements for 3D constructs are spatiotemporal
control of the 3D cellular microarchitecture and ECM
distribution (Lu et al., 2013). Available literature underlines
the advantage of aligned nanofibers over randomly oriented
fibers to mimic tendon tissue. However, ideal fiber characteristics,
such as diameter, pore size, spacing and angle are still under
debate. The oldest production techniques use a “top-down”
approach, in which cells are seeded onto a designed scaffold.
After proliferation, the seeded cells need to produce new
ECM. Complex functional tissues are hard to design top-down
and size is confined by diffusion limitations (e.g., oxygen
diffusion, 100–200 µm) (Radisic et al., 2006; Loh and Choong,
2013; Lu et al., 2013; Richards et al., 2016). By “bottom-up”
engineering, microscale tissue building blocks with specific
micro-architecture are carefully assembled together to build
larger constructs. Different building blocks can consist of
different cell populations and biomaterials, creating micro-
organs (Lu et al., 2013). Another classification can be made
regarding conventional methods vs. additive manufacturing
technologies. A more detailed overview of the techniques
discussed is shown in Figure 5.
Self-Assembly
In this bottom-up method, very small nanofibers (<100 nm
to a few nm) are produced through weak interactions. The
productivity of this technique is rather low and the process
is only under limited control (Alghoraibi and Alomari, 2018).
Cornwell et al. (2007) improved the mechanical strength of self-
assembled collagen threads, formed by extrusion into a bath
of fiber formation buffer, by dehydrothermal treatment and
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FIGURE 5 | Advantages and disadvantages of the available fibrous scaffold fabrication techniques for tendon tissue engineering.
ultraviolet crosslinking. Another way to improve strength is by
administering strain prior to fiber drying. Through this way,
the ultimate tensile strength (UTS) in pre-stretched fibers is
reported to be five times higher (Kew et al., 2011). The research
group of Attenburrow compared different co-agents to produce
extruded collagen fibers. They aimed to preserve the advantages
of extruded collagen fibers and, at the same time, upregulate
production and stability. Both polyethylene glycol and NaCl are
considered highly suitable to reconstruct collagen fibers (Zeugolis
et al., 2008a,b). Due to the poor mechanics of collagen, the
formation of stable 3D constructs is not yet achieved, and the
high costs associated with this technique hamper research and
practical applications (Lu et al., 2013). Another disadvantage of
collagen extrusion techniques is their limited efficiency as the
production process is very time consuming (Kew et al., 2011).
Phase Separation
Phase separation is generated by introducing a non-solvent.
Physical incompatibility between polymer and solvent results in
separation and formation of nanofibers after gelation. However,
these scaffolds have a heterogeneous pore structure, which
makes them unsuitable for tissue engineering (Lu et al., 2013).
Moreover, the porosity needs to be interconnected to allow
cell infiltration and diffusion of culture media (Freyman et al.,
2001). An alternative is thermally induced phase separation, but
only few (synthetic) polymers are suitable for this process and
short fibers are obtained, limiting the in vitro model capability
(Alghoraibi and Alomari, 2018).
Freeze-Drying
Using this technique, the polymer is frozen (−80◦C) to obtain
a porous structure, after which the formed ice crystals are
sublimated (De France et al., 2018). This process is more
appropriate for biomedical applications due to the lack of
organic solvents and the more simple method, yet it is difficult
to obtain hierarchically organized scaffolds with this method
(Alghoraibi and Alomari, 2018). Collagen freeze-drying is
regularly used to create skin regeneration scaffolds, but too
little structure is present to consider this approach for tendon
applications (Freyman et al., 2001). Caliari and Harley (2011)
provided alignment by adding a collagen-glycosaminoglycan
melt to a polytetrafluoroethylene-copper mold before freeze-
drying. Equine tendon cells showed increased attachment to the
surface, metabolic activity, and cell alignment, when compared
to an isotropic (non-aligned) scaffold. By including directional
solidification, contact guidance cues were implemented and a
more physiologically relevant model was created (Caliari and
Harley, 2011). This model was also utilized by Grier et al. (2017)
to study the influence of pore size and stiffness on tenocyte
metabolic activity and gene expression. Increased tenogenic gene
expression and cell activity was seen for higher crosslinking
densities and smaller pore sizes (Grier et al., 2017).
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FIGURE 6 | Advantages and disadvantages of bioreactors used in tendon tissue engineering. Adjusted from Ligagen R© L30–4C (DynaGen systems; Dartmouth, NS,
Canada), BioFlex R© culture plates and TissueTrain R© (Flexcell International; Hillsborough, NC, United States), and BOSE BioDynamic R© 5,200 multi-chamber (TA
Instruments; New Castle, United Kingdom).
Microfluidic Alignment
While contact guidance in 2D cultures is provided by culture
plastic surface modifications (see section “Two-Dimensional
(2D) Models” above), microfluidic alignment is a popular
method in 3D cultures to create scaffolds with well-defined
geometry. By collagen polymerization inside channels (often in
polydimethylsiloxane, PDMS) fiber alignment is realized. Lee
et al. (2006) examined the effect of different channel widths
on alignment. They considered this technique suitable for cell
studies on movement, signaling, growth and differentiation
pathways, although it must be mentioned that they did observe
a reduced alignment efficiency of threads with increasing
channel width, resulting in a greater angle between fibers
(Lee et al., 2006; Uquillas et al., 2012). Occhetta et al. (2013)
combined micro-molding within PDMS stamps and hydrogel
photopolymerization to establish an in vitro model. Instead of
seeding, they encapsulated BM-MSCs and endothelial cells in
the hydrogel, which is much more efficient, more physiologically
relevant and more compatible with vascular supply (Occhetta
et al., 2013; Waheed et al., 2019).
Electrochemical Alignment
An electrical current can be applied to the collagen solution
to produce densely packed, aligned fibers, the so-called ELAC
threads, as already mentioned earlier. Advantages of this
technique are low cost, different geometry formation by changing
electrode geometry and improved controllability (Uquillas et al.,
2012). Cheng et al. (2008) were the first to produce ELAC threads.
Collagen bundles were formed with an average diameter of 50–
400 µm, which is much larger than the fiber diameter achieved
with self-assembly. Tenocytes seeded on ELAC threads were
able to survive and proliferate on the bundles. However, only
half the strength of native tendon was reached (Cheng et al.,
2008). The group of Uquillas was able to increase the mechanical
strength by crosslinking ELAC with 2% genipin (Uquillas et al.,
2012). However, to increase biomimetic fibril structure, a smaller
diameter is desirable (±100 nm range) (Smith, 2008; Kew et al.,
2011Xie et al., 2020).
Electrospinning
Non-modified Electrospinning Structures
Using electrospinning, ultrafine fibers within nanometer
range are produced which enables tendon tissue engineering
applications. The micro- and nanostructure can be precisely
designed by altering process parameters and polymer solution
(De France et al., 2018). Fibers are produced through subjecting
natural or synthetic materials in a syringe pump to a high-power
electrical field, surface tension is overcome by electrostatic
forces, and a jet of fluid is ejected onto a grounded collector
(Zhong, 2016). Electrospun nanofibers have a high surface
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area to volume ratio, mimic the tendon ECM and, therefore,
facilitate cell attachment and metabolic activity (Sahoo et al.,
2006). Many derivative methods of traditional electrospinning
have been developed in which highly anisotropic structures
are created, thus, applicable for tendon applications, such as
wet spinning, melt electrospinning, or coaxial electrospinning.
In wet electrospinning, the usual metal collector is replaced
by a liquid bath. If the polymer substance is heated during
extraction, it is called melt electrospinning. A cylindrical
collector is typically used, resulting in more aligned fibers
when compared to a traditional setup (Alghoraibi and Alomari,
2018; Sensini and Cristofolini, 2018). Coaxial electrospinning
combines two polymer solutions in a core-shell setup. For a more
comprehensive technical description of the various techniques,
we refer to other reviews (Alghoraibi and Alomari, 2018; Sensini
and Cristofolini, 2018).
In various electrospinning studies, scaffolds are evaluated
for tendon tissue engineering by the (un)successful tenogenic
MSCs differentiation. For example, James et al. (2011) used
PLGA to compare an electrospun matrix with a 2D film.
Enhanced collagen I expression was observed after growth
factor supplementation in both matrices, but scleraxis expression
was only upregulated when AT-MSCs were cultured on the
electrospun matrix. The tensile strength of the scaffold was
within the range measured for regular human flexor tendons
though not sufficient for those perceived by Achilles tendons
(Sensini and Cristofolini, 2018). Full-thickness cell infiltration
was evaluated in multi-layered aligned electrospun PCL matrices
by Orr et al. (2015). In that study, it was demonstrated that
fiber alignment has no positive effect on ECM production
and cell infiltration after 28 days of culture, but tenomodulin
expression by AT-MSCs and mechanical properties were
increased (Orr et al., 2015). Yang et al. (2016) combined
PCL and methacrylated gelatin onto a rotating vessel. Using
these scaffolds, ECM structure and mechanical anisotropy
were mimicked, and tenocytic differentiation of AT-MSC was
induced. In the study of Ramos et al. (2019), in which PCL
was combined with cellulose acetate, decreased fiber diameter
and tensile strength were observed with increasing cellulose
acetate concentrations. The latter illustrates that the balance
between the hydrophobic nature of PCL and the hydrophilic
nature of cellulose acetate is difficult to realize in order to
promote cell interactions and, at the same time, provide
sufficient strength.
Natural materials are less frequently used as a mono-
material in electrospinning. Ghiasi et al. (2014) designed nano-
coated textured silk yarns for tendon and ligament scaffold
application. A better surface roughness was achieved, resulting
in a more porous surface to support cell migration to the inner
part of the scaffolds. Unfortunately, the mechanical strength
of the constructs was insufficient (Ghiasi et al., 2014). Tu
et al. (2013) combined a PLA core with a collagen sheath
to create aligned fibers with high mechanical strength and
adequate biocompatibility. PLA/PCL/collagen scaffolds were
fabricated by Xu et al. (2014), by using a dynamic water
flow system for electrospinning. When tendon stem cells were
seeded onto the scaffolds, they showed good proliferation and
increased gene expression in response to mechanical stimulation
(Xu et al., 2014).
Textile Manufacturing Techniques
To reconstitute filamentous collagen structures and improve
the mechanical strength, electrospinning configurations have
been modified to produce bundles and yarns and have been
combined with different textile production methods such as
braiding, knitting, and weaving. Sahoo et al. (2006) designed a
nano-microfibrous polymer tendon scaffold by electrospinning
PLGA onto a knitted PLGA scaffold, as such bypassing the poor
cell seeding results associated with braided fabrics. Although
favorable cell properties were obtained, mechanical properties
were far from comparable with native tendon (Sahoo et al., 2006).
Barber et al. (2013) braided three, four, or five, aligned bundles
of electrospun PLA nanofibers. The three-bundle braided
scaffold showed superior mechanical characteristics compared
to the other groups. Tenogenic differentiation of MSCs on
the three-bundle scaffolds was observed after supplementation
of tenogenic growth factors and upon applying cyclic tensile
strain, highlighting the in vitro potential (Barber et al., 2013).
Braiding, however, results in tightly packed biomaterials, having
a negative impact on cell proliferation and infiltration (Laranjeira
et al., 2017). Czaplewski et al. (2014) investigated the effect of
fiber chemistry and braiding angle on the scaffold’s mechanical
properties and tenogenic differentiation using human induced
pluripotent stem cells. They showed that large angles, thus
less dense packaging, better supported tenogenic differentiation
(Czaplewski et al., 2014). Vuornos et al. (2016) compared
different medium compositions, biomaterials and scaffold
structures in order to identify the most efficient set-up to
produce tendon-like matrix in vitro. When compared to foamed
PLA/PCL scaffolds, braided PLA scaffolds were superior both
for cell characteristics and tenogenic differentiation of AT-MSCs.
Moreover, the PLA scaffolds expressed a similar elastic modulus
as native Achilles tendons (Vuornos et al., 2016).
Hybrids
Both production technologies and biomaterials mentioned above
can be extensively combined to establish the ideal in vitro
tendon model. However, it is mandatory that the structure
does not become too complex to be generally accepted and
stays controllable. Each single component should be evaluated
for necessity and added value. Wang et al. (2018) designed a
novel scaffold for tendon regeneration by combining a PCL
shell with an electrospun PCL/polyethylene oxide core. The
scaffold had tendon-like mechanical properties and the cultured
tenocytes expressed a higher amount of phenotypic markers
when compared to isotropic control scaffolds (Wang et al.,
2018). Despite the achieved mechanical strength, they were not
able to mimic native ECM. As the synthetic polymers used
in this model did not contain the functional chemical groups
available for cellular binding, this setting is deemed not suitable
as a good in vitro tendon model. The group of Rinoldi et al.
(2019) combined coaxial extrusion printing and wet spinning
of a bioink composed of alginate and methacrylated gelatin,
which allows cell encapsulation. Tenogenic differentiation of
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BM-MSCs and aligned cell/fiber orientation was successfully
achieved (Rinoldi et al., 2019). Laranjeira et al. (2017) designed
an artificial tendon construct consisting of continuously aligned
nanofiber threads (PCL/chitosan) reinforced with cellulose
nanocrystals. Biocompatibility, cell elongation, and anisotropic
organization was assessed after seeding tenocytes and AT-
MSCs. Tenogenic differentiation of AT-MSCs was reached and
tenocyte dedifferentiation prevented (Laranjeira et al., 2017).
Unfortunately, vascularization was not provided which hampers
extensive use of this model. Wu et al. (2017) produced a
nanofibrous, woven biotextile, made of electrospun PCL yarns
interlaced with PLA multifilaments. The woven scaffolds had a
significantly larger pore size and showed better mechanics than
the non-woven controls. Tenocyte and AT-MSCs proliferation
and gene expression were upregulated in the woven scaffolds.
Subsequently, after supplemental seeding of human umbilical
vein endothelial cells (HUVECs) on the woven scaffolds with AT-
MSCs and tenocytes, tenogenic gene expression further increased
(Wu et al., 2017). Although vascularization building-blocks are
included in this model, the exact function of the HUVECs was
not evaluated in this study.
More than one hundred scientific papers and several reviews
have described different electrospun nanofibers which can be
used for tendon tissue engineering because of their ability to
mimic ECM structure and its production flexibility (Sensini and
Cristofolini, 2018). However, current models still require some
optimization before a standalone model can be established. Most
electrospinning set-ups are not suitable for cell encapsulation,
which is more physiologically relevant and significantly more
compatible with the incorporation of vascular supply than
cell seeding (Waheed et al., 2019). In addition, effective
vascularization has not yet been achieved in electrospun scaffolds
and homogeneous seeding is often difficult (Merceron et al.,
2015). The search for the ideal material (or combination of
materials) is still ongoing. A combination of PCL and chemically
modified collagen to combine a certain mechanical strength with
biocompatibility, could be promising for a tendon in vitro model
(Zeugolis et al., 2008a; Uquillas et al., 2012).
3D Bioprinting
In additive manufacturing, different processes are used to
replicate 3D objects layer-by-layer by computer-aided design
with controlled geometrical properties (Sculpteo, n.d.; De France
et al., 2018; Vaezi et al., 2018). The conventional chemical
engineering methods (as discussed above) fail to control
exact pore size, pore geometry, and spatial distribution of
the pores (Vaezi et al., 2018). Therefore, advanced additive
manufacturing techniques are gaining popularity in recent tissue
engineering strategies.
A popular technique is 3D bioprinting, in which a bioink
is used to mimic the ECM and encapsulate the desired cells
(Laternser et al., 2018). The most promising techniques are
direct printing techniques, in which a 3D gel is directly
printed in a single processing step (De France et al., 2018).
The most common methods are micro-extrusion, inkjet
and/or light−induced methods, which include laser−assisted
bioprinting and stereolithography (Mandrycky et al., 2016).
Bioprinting must be carefully prepared by collecting accurate
tissue information, transferring information to a suitable
computer-aided design model and, finally, by creating a stable
structure (He et al., 2018). Specific demands for material and
cell source have been listed: (i) the material should maintain
cell viability and promote specific activity after printing, (ii) a
great number of encapsulated cells needs to be available and
(iii) cells should be able to survive the (post-)printing process
(Zhang et al., 2017).
Extrusion-based 3D printing is a direct printing method which
is widely researched and identified as an appropriate method for
bone, cartilage and adipose tissue engineering. In contrast, this
technique is still in its infancy for tendon tissue engineering,
(Costantini et al., 2016; Sun et al., 2016; Naghieh et al., 2017;
De Mori et al., 2018; Fernandez, 2019; Colle et al., 2020; Tytgat
et al., 2020; Van Damme et al., 2020). For example, Sun et al.
(2016) have demonstrated the overall superior qualities of 3D
printed scaffolds over freeze-dried scaffolds for cartilage tissue
engineering. Different extrusion-based bioprinters are designed
to deposit various biopolymers, hydrogels and many different cell
types to produce 3D bio-constructs (Vaezi et al., 2018). Merceron
et al. (2015) developed a muscle–tendon unit construct, suitable
as in vitro model by applying pneumatic pressure and heat
to extrude filaments. The tendon part consisted of PCL co-
printed with fibroblasts (NIH/3T3). The polymers were printed
separately from the cell-laden bioinks by interspersing rows,
and this process was repeated layer-by-layer with the whole
construct being crosslinked at the end. After 7 days of culture,
good cell viability was observed as well as the characteristic cell
morphology. In addition, the construct was repeatedly produced
with precise dimensional accuracy (Merceron et al., 2015).
Laternser et al. (2018) described a novel drug screening platform
for tendon and muscle applications. A tendon tissue model was
designed by alternating layers of bioink and rat tenocytes in
a dumbbell shape around postholder inserts in a microplate.
The printed tenocytes showed high viability and maintained
good differentiation, suggesting a good but rather basic approach
for tendon drug screening (Laternser et al., 2018). Stanco
et al. (2020) incorporated AT-MSCs in a nanofibrillar cellulose
and alginate bioink for 3D printing, to evaluate tenogenic
differentiation and suitability for tissue engineered constructs.
The AT-MSCs survived the printing process and displayed the
favorable tenogenic-like phenotype without an inflammatory
response to the bioink. The research group reported a first
approach for upscaling the clinical use of 3D printed tendon
constructs, opening up possibilities for model design (Stanco
et al., 2020). Park et al. (2018) designed a 3D bioprinted
scaffold sleeve composed of PCL, PLGA and β tricalcium
phosphate to reconstruct an anterior cruciate ligament. The
scaffold was seeded with MSCs and evaluated in bone-tunnels
of an in vivo rabbit model to assess bone-tendon regeneration.
In the treatment groups, improved bone-tendon healing was
observed at all time points and thus the authors concluded that
their scaffold has the potential to accelerate bone-tendon healing
in anterior cruciate ligament reconstruction (Park et al., 2018).
Unfortunately, MSCs were still seeded afterward in this model
instead of being encapsulated.
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Recently, incorporating dECM in bioinks has attracted
attention in the field of tissue engineering (Zhang et al., 2017;
Santschi et al., 2019). Toprakhisar et al. (2018) developed a bioink
from tendon dECM and evaluated murine fibroblast (NIH/3T3)
viability and morphology. Vascularization, however, was not
included in this model and cultures were only followed for 3 days.
Furthermore, fibers were not properly aligned in contrast to fibers
obtained with electrospinning. Regardless, the use of dECM in an
in vitro model is limited due to the fact that its composition is
variable and needs to be analyzed before every procedure.
Current drawbacks of direct bioprinting for tissue engineering
applications include the low achievable sizes and the limited
number of suitable materials (De France et al., 2018). When
considering in vitro studies, the small scaffold size is not a
constraint, but better fiber alignment has to be achieved and
the impact of mechanical stimulation on 3D printed tendon
constructs still needs to be evaluated.
The use of computer-aided design in bioprinting enables
the combination with other fabrication techniques such as
electrospinning. Jordahl et al. (2018) used 3D jet writing (a
combination of electrospinning and 3D computer-aided design)
to create bone constructs. Stability was obtained with PLGA and
MSCs were seeded (Jordahl et al., 2018). In this approach, the
benefits of both bioprinting and electrospinning were combined.
When vascularization would be integrated in this model, this
approach could be suitable for in vitro tendon models as well,
providing a breakthrough in this research field.
ADVANCED: INCORPORATING
BIOREACTORS
Bioreactors are used to sustain the life of cells and tissues
in vitro, while under the influence of dynamic, but controllable,
physiological conditions (Youngstrom and Barrett, 2016;
Ozbolat, 2017). Many different bioreactors have been used in
tendon tissue engineering, as chronologically listed by Dyment
et al. (2020). As already mentioned above, mechanical loading is
essential to mimic tendon physiology, as cell signaling systems
are modified through mechano-transduction pathways (Chiquet
et al., 2009; Buxboim et al., 2010; Riehl et al., 2012; Govoni et al.,
2017; Wang et al., 2017). Therefore, only bioreactors applying
mechanical stimulation are discussed in this literature review,
with the focus on parameters like mechanical stimulation,
stability, and repeatability for fundamental research. A main
drawback associated with bioreactors is that all researchers
have used different protocols and it is challenging to compare
studies. An overview of the cited bioreactors and corresponding
stimulation protocols is given in Figure 6 and Table 1. Tension
protocols ranged from 0 to 10% (magnitude) and a frequency
between 0.0167 and 1 Hz.
To study tendon homeostasis under mechanical load,
biomechanical parameters such as strength, toughness and
viscoelasticity are evaluated (Murata, 2012). Other tensile
properties for characterization of biomaterials are UTS, yield
or failure load/stress/strain, and elasticity. While UTS displays
the maximum stress before physical deformation disrupts the
material irrevocably, the yield load/stress/strain displays the
stress a material can tolerate before physical deformation occurs
and the failure load/stress/strain illustrate the properties at the
moment of failure (Malkin and Isayev, 2012b). Stress is the
applied force over cross-sectional area. Strain, however, is a
measure for the deformation in response to the applied stress. The
ratio of stress over strain is called elasticity (or Young’s modulus)
and illustrates how force results in deformation of the tissue
(Malkin and Isayev, 2012a).
To allow cells to respond in an in vitro model similarly as
in vivo, they should experience the physiological stiffness of the
scaffold and undergo physiological levels of strain (Sensini and
Cristofolini, 2018). The tendon response to mechanical load is
varying depending on the location in the body, the age of the
animal, and the differentiation level of the cells (Patterson-Kane
et al., 2012). As different results are observed in vivo compared
to in vitro, measurements cannot simply be extrapolated and
should be evaluated ‘relatively’ (Smith and Goodship, 2008). For
example, in vivo the strain of the SDFT in galop is measured 12-
16%, while in vitro 15–17% is measured as ultimate tensile strain
(Gerard et al., 2005; Thorpe et al., 2010). The effects of mechanical
forces on MSC differentiation have been widely studied (Huang
et al., 2009; Youngstrom et al., 2015; Youngstrom et al., 2016;
Fahy et al., 2017). Depending on the mechanical stimulation
protocol and MSC source used, differentiation into an osteogenic,
chondrogenic, adipogenic, or tenogenic phenotype is observed
(Delaine-Smith and Reilly, 2012). Therefore, the appropriate
strain/stretch protocols for MSCs in a tendon environment
should be identified in order to support tenogenic differentiation
of the MSCs and, more importantly, the secretion of tenogenic
trophic factors. In a study of Youngstrom et al. (2015) equine
BM-MSCs were seeded on decellularized SDFT, subjected to 3
and 5% strain, 0.33 Hz for up to 1h daily and compared to
static controls (0%). Upregulation of scleraxis expression was
seen both in the 3 and 5% group compared to the control group,
albeit only significant in the 3% group. Other evaluation criteria
such as gene expression, elastic modulus, and UTS, were also
superior in the 3% group. The 5% strain approach gave results
in between the 0 and 3% strain group, leaning more toward the
0%, suggesting that 3% strain is more suitable for SDFT studies
(Youngstrom et al., 2015). Human tenocytes cultured on rat tail
collagen gels, on the other hand, expressed anabolic changes in
matrix metalloproteinases and tenogenic genes when exposed to
5% strain, 1 Hz (Jones et al., 2013). In a study of Wang et al.
(2013) in which rabbit Achilles tendons were subjected to 0–
9% strain, 0.25 Hz for 8 h daily, 6% cyclic tensile strain was
identified as optimal to maintain structural integrity and cellular
functions (Wang et al., 2013). An electrospun PLA/PCL/collagen
scaffold, seeded with rat tendon stem cells was subjected to cyclic
tensile strain with different magnitudes and frequencies by Xu
et al. (2015). The optimal protocol for enhancing tenogenic gene
expression was determined as 4% and 0.5 Hz (Xu et al., 2015).
Burk et al. (2016) seeded equine AT-MSCs on a decellularized
tendon scaffold. When the scaffolds were exposed to 2% strain
and 1 Hz, the viability decreased while tenogenic gene expression
(tenascin-C and scleraxis) increased. Cell alignment was present
on all scaffolds (static vs. cyclic stretching) and was more
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TABLE 1 | Overview of bioreactors used in tendon tissue engineering which all apply mechanical stimulation.
Study Biomaterial + Cells Bioreactor Stimulation Results









Uniaxial strain, 1.25 N over
5 days.
1 cycle/minute in alternating
1h periods of mechanical
loading and rest.
UTS and E comparable with
fresh tendons.
Cells reoriented parallel to the









Uniaxial strain, 1.25 N over
5 days.
1 cycle/minute in alternating
1 h periods of mechanical
loading and rest.





Rabbit AT Clamp grips, in medium 8 h/day, 0–9%, 0.25 Hz.
6 days




6% cyclic strain optimal for
structure integrity and cellular
function.




10% tension, 1 Hz, 90◦
torsion.
7 days
20% lower UTS in
decellularized grafts vs. normal








0%, 3%, 5% strain, 0.33 Hz,
up to 1 h/day, 11 days.
Gene expression, elastic
modulus and UTS favorable
with 3%.
Burk et al., 2016 Decellularized equine
SDFT + AT-MSCs
Clamp grips, in medium 2% strain, 1 Hz, short (2
stretches/cycle) and long (3
stretches/cycle) protocol.
Short mechanical stimulation
best cell alignment, successful
tenogenic differentiation.





UniFlex culture plate +
Flexcell Tension System
(Flexcell International)
Continuous strain (8%, 1 Hz).
Intermittent strain (1 h on/5 h
off, 4% 0.1 Hz).












12 h, 4% or 8% Tenogenic gene expression



















12 h/day, 10%, 1 Hz Cell/ECM alignment superior,
increased ECM deposition and

















3D loading Altman et al.,
2002







Translational (10%, 2 mm) and
rotational strain (25%, 90◦).





and oriented collagen fibers.
Garvin et al.,
2003
Collagen type I gel +
avian tenocytes
Tissue Train 3D Culture
System (Flexcell
International), culture
plate with 2 anchors
1 h/day, 1% elongation, 1 Hz,
11 days
Tenogenic gene expression and
linear morphology.
Stronger loaded constructs vs.
non-exercised controls.
(Continued)
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TABLE 1 | Continued
Study Biomaterial + Cells Bioreactor Stimulation Results
Scott et al.,
2011




Tissue Train 3D Culture
System (Flexcell
International), culture
plate with 2 anchors
Static vs. cyclic load, 2 h/day,
5%, 0.1 Hz for 1, 2 or
3 weeks.
2 h/day, 0, 2.5, 5, 7.5, or
10%, 0.1 Hz for 2 weeks.
2 h/day, 10%, 0.1 Hz,
10,100, or 1,000 cycles/day,
10s rest
Tenogenic gene expression
increased with cyclic loading.
Gene expression increased with
increasing magnitude, with 10s
rest and increased repetitions.
Jones et al.,
2013
Collagen type I gel +
human AT tenocytes
Tissue Train 3D Culture
System (Flexcell
International), culture
plate with 2 anchors
5% cyclic uniaxial strain,











1 h/day, 5%, 1 Hz (3,600
cycles/day), 225 N, 7 and
21 days
Cell orientation more uniaxial,
tendon gene upregulation due
to dynamic loading.


















20 min/day, 10%, 0.67 Hz,
14 days
Mechanical properties
improved, more gel contraction












3× 15–30–60 min of activity
alternated with 15–30–60 min
off, 2×/day.
3%, 0.33 Hz, 7 days.
Perfusion: 100 µm/s
Collagen production and














BM-MSCs adherence to fibers,
tenogenic differentiation when
differentiation medium + cyclic
tensile strain.






45◦ rotational and 3.5 mm
translational deformations,
0.0667 Hz
Exact control of environmental
conditions possible, load and
stiffness of silk scaffolds
matches native ACLs.
Talò et al., 2020 PLA-PCL/Collagen




Cyclic tensile strain, 3 h/day,
2, 4, and 8 and 0.3, 0.5, and
1.0 Hz, 7 days
No difference in cell viability.
Tenogenic gene expression
highest with 4%, 0.5 Hz.
ACL, anterior cruciate ligaments; AT, achilles tendon; AT-MSCs, adipose tissue-derived mesenchymal stem cells; BM-MSCs, bone marrow-derived mesenchymal stem
cells; E, elastic modulus; HUVECs, human umbilical vein endothelial cells; PCL, poly-ε-caprolactone; PLA, polylactic acid; SDFT, superficial digital flexor tendon; TSPCs,
tendon stem/progenitor cells; UTS, ultimate tensile strength.
pronounced compared to monolayer cell cultures, indicating the
importance of ECM mimicry (Burk et al., 2016).
Not only the amount of strain applied is significant, the
regimen used is also of great importance. Continuous static
loading not only affects tendon phenotype negatively, it is also not
representative for the in vivo situation. Optimal for physiological
mimicking is, therefore, the application of intermittent cyclic
loading (Cao et al., 2006; Scott et al., 2011). Different studies show
favorable cell characteristics (elongation, metabolic activity, gene
levels and protein production) administering intermittent cyclic
strain, while a negative influence of continuous cyclic strain is
frequently reported (Cao et al., 2006; Riboh et al., 2008; Bosworth
et al., 2014; Youngstrom et al., 2015; Atkinson et al., 2020).
For example, Riboh et al. (2008) compared the application of
constant versus intermittent cyclic strain in a 2D, Flexcell Strain
Unit (Flexcell International; Hillsborough, NC, United States).
Continuous cyclic strain inhibited cell proliferation and collagen
production in tenocytes, sheath fibroblasts, BM-MSCs and AT-
MSCs. Intermittent cyclic strain, on the other hand, increased
cellular proliferation and total collagen production per cell
(Riboh et al., 2008).
Ex vivo Loading
To define mechanical characteristics of tendons, explants can
be loaded onto bioreactors immediately after dissection or after
decellularization. For defining biomechanical characteristics of
in vivo tendons, ex vivo loading is the most appropriate method.
However, mechanical properties vary due to the applied strain
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protocol, the size of the dissected tissue, and the decellularization
process if applicable (Kuo et al., 2010; Youngstrom and
Barrett, 2016). A custom bioreactor system (Ligagen L30-4C,
DynaGen systems; Tissue Growth Technologies, Minnetonka,
MN, United States) was used by two research groups to
test the influence of oscillatory, uniaxial tensile stimulation
on decellularized rabbit flexor tendons. Both reseeded the
constructs with different cell types (AT-MSCs combined with
fibroblasts, and tenocytes, respectively) and compared either
seeded constructs to fresh tendons and unloaded constructs
(Angelidis et al., 2010) or to unseeded tendons (Saber et al.,
2010). Both studies found that the seeded tendon constructs
showed mechanical characteristics (UTS and elastic modulus)
comparable to those of freshly extracted tendon (Angelidis et al.,
2010; Saber et al., 2010). Lee et al. (2013) evaluated porcine
anterior tibial tendons for human ligament reconstruction in
the bioreactor where the ligament was fixated vertically at both
ends and tension up to 120% was applied while rotation was
simulated also (0–90◦). Decellularized grafts initially showed
20% lower UTS than normal tendon, but after 7 days of
physical stimulation, the UTS was doubled, indicating that these
constructs do have potential for human ligament reconstruction
(Lee et al., 2013). Based on research with these ex vivo
models, our knowledge about tendon physiological mechanics
has substantially improved. Nevertheless, these models are too
variable, and therefore, inadequate to study cellular responses
in vitro (Wang et al., 2017).
2D Loading Models
As 2D models are still used to examine cell behavior [as discussed
in section “Two-Dimensional (2D) Models”], implementing
mechanical load is achievable in 2D loading bioreactors. Cells
are cultured in modified cell-plates, allowing execution of a
specified stretch protocol after cell adhesion to the bottom
of the well. Both custom-made and commercial models are
available and are usually placed within a standard incubator.
The disadvantage of these 2D bioreactors is that they can
only provide insights in cellular responses but not cell–matrix
interactions (Wang et al., 2017; Yu et al., 2020). Zhang
and Wang investigated tendon mechano-biological responses
through different in vivo and in vitro experiments. For the in vitro
experiment, mice AT/patellar tendon tenocytes and tendon stem
cells were extracted, plated in silicone dishes and mounted on
a custom-made stretching device (Wang et al., 2003). Their
main finding was that a cell-dependent response occurred on the
applied strain regimes. Tendon stem cells responded to moderate
mechanical stretching (4%) with increased tenocyte-related gene
expression (collagen I, tenomodulin). Exaggerated mechanical
loading (8%) resulted in both increased tenocyte and non-
tenocyte-related gene expression, suggesting differentiation into
other cell types. Tenocytes, on the other hand, did not express
this strain-dependent response. The researchers concluded that
moderate mechanical loading could be beneficial in tendon
homeostasis (Zhang and Wang, 2013). The combined effects of
macromolecular crowding [where an attempt is made to create
an optimal intracellular environment by the administration
of various macromolecules, including different proteins and
nucleic acids (Hata et al., 2018)] and mechanical loading
in a commercially available MechanoCulture FX (CellScale,
Biomaterials Testing; Waterloo, Canada) were evaluated by
Gaspar et al. (2016) Increased alignment was seen together
with increased ECM deposition, but with similar cell metabolic
activity and viability. The same group later conducted a similar
study using other cell types (tenocytes, BM-MSCs and dermal
fibroblasts). While they successfully achieved maintenance
of proper tenogenic phenotype by combining mechanical
loading and macromolecular crowding, they failed to induce
tenogenic differentiation of BM-MSCs and trans-differentiation
of fibroblasts (Gaspar et al., 2019).
3D Loading Models
2D bioreactors are only suitable for loading monolayer cell
cultures, therefore, a more sophisticated approach for 3D
biomaterial scaffolds is needed (Yu et al., 2020). Various
(bio-)materials can be loaded, and many alternative mount
methods are available. For example, the end of the samples
can be fixed with grips, but fixation between anchors is also
possible. These reactors, however, lack vascularization, as the
static presence of culture medium is not representative for in vivo
blood flow. Additionally, culture medium is often individually
provided per sample, limiting the inter-sample repeatability
(Jaiswal et al., 2020). In the bioreactor of Altman et al., BM-
MSCs seeded onto collagen I gel matrices were grown in 12
individual tubes in between two anchors (2 cm apart) for ligament
tissue engineering. The complete system was designed to fit
in a standard incubator. After application of translational and
rotational strain, gene expression, cell alignment, and collagen
fiber orientation suggested the BM-MSCs differentiated into
ligament cells (Altman et al., 2002). Unlike some ligaments,
tendons mostly experienced unidirectional stretching parallel
to their orientation (Wang et al., 2017). The implementation
of rotational strains is, therefore, unnecessary for tendon
bioreactors. Garvin et al. (2003) inserted tendon constructs, made
of a mixture of collagen I gel and tenocytes, in a commercially
available Tissue Train 3D Culture System consisting of Tissue
Train culture plates with two anchors (Flexcell International;
Hillsborough, NC, United States). After 11 days of culture,
constructs exposed to uniaxial displacement were stronger than
unloaded counterparts, yet far weaker than native adult tendons
(Garvin et al., 2003). The same bioreactor was used by Scott
et al. (2011) to examine different strain protocols on bioartificial
tendons, made of a cell-collagen mixture. Tenogenic gene
expression (scleraxis and collagen I) in MSCs was increased by
administering cyclic load (versus static load) with increasing
magnitude (0, 2.5, 5, 7.5, or 10%), and with implementing 10s rest
periods in between loading cycles and with increasing repetitions
(10,100, or 1,000 cycles/day) (Scott et al., 2011). Bosworth
et al. (2014) utilized the BOSE BioDynamic chamber 5110
(TA Instruments; New Castle, United Kingdom) for evaluating
static (0%) versus cyclic loading (5% strain, 1 Hz for 1 h
per day) on electrospun PCL yarns seeded with MSCs. Results
showed increased cell proliferation, matrix deposition and gene
expression in response to intermittent cyclic loading (Bosworth
et al., 2014). Wu et al. (2017) cultured three different cell types
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(tenocytes, AT-MSCs and HUVECs) on synthetic electrospun
fibers (PCL/PLA scaffolds) and stated that dynamic culture
in a custom-made mechanical stimulation device promoted
collagen production and tenogenic differentiation (Wu et al.,
2017). Atkinson et al. (2020) demonstrated with the use of a
custom-designed bioreactor that equine tendon constructs within
collagen I gels, analogous to other species, show improved
mechanics when exposed to cyclic strain (Atkinson et al., 2020).
Stretch and Perfusion Models
As culture medium perfusion was incorporated in these
bioreactors to mimic blood flow, these models are discussed
separately. With the implementation of culture medium
perfusion, cells have superior access to oxygen and nutrients
which leads to increased proliferation rates (Wendt et al., 2006).
Unidirectional perfusion is shown to create heterogeneous
spreading of the cultured cells within 3D scaffolds, whereas
bidirectional flow leads to more uniformly colonized scaffolds
(Wendt et al., 2006; Du et al., 2009). Barber et al. (2013)
braided nanofibrous scaffolds out of PLA and seeded them with
BM-MSCs. Instead of replacing the differentiation medium
every 2–3 days, active unidirectional perfusion (20 ml/min) was
implemented (Barber et al., 2013). Hohlrieder and his group
tackled the need to control exact environmental conditions to
evaluate cell behavior. A new bioreactor was designed with 10
independent vessels to evaluate braided silk scaffolds for ligament
graft design. Mechanical load and unidirectional perfusion were
controlled per vessel (Hohlrieder et al., 2013). Talò et al.
(2020) designed an oscillating stretch-perfusion bioreactor with
programmable uniaxial strain for evaluating decellularized
SDFT. Bidirectional perfusion was administered after MSC
seeding, and the effect of stretching cycles was evaluated. The
bioreactor has been declared unique and cost-effective for the
incorporation of multiple chambers for controlling different
biological and mechanical protocols (Talò et al., 2020).
Conclusive, different custom-made and commercially
available bioreactors are being used with different mechanical
loading protocols. The variety within these studies complicates
translational research and hampers scientific progress (Beldjilali-
Labro et al., 2018). For a universal tendon model, an optimal
bioreactor with a multiple-chamber, multiple-sample set-up
should be designed and used across laboratories, since different
experimental conditions and appropriate controls are required
(Jaiswal et al., 2020). The stretch-perfusion bioreactors are the
most advanced and the most suitable for this application, but a
universal loading protocol is lacking.
EXPERT: AVAILABLE TENDINOPATHY
MODELS
Two major techniques are available to provide a
pathophysiological tendon model, namely scratch models
and overstimulation-based approaches (Figure 7). To mimic
the tendinopathy environment with its physical damage and
mechanical disruption, researchers have supplemented various
cytokines and enzymes to different in vitro cultures and animal
models. It is evident, however, that when the physiological
tendon model does not mimic in vivo tendon tissue regarding
complexity and functionality, the “-pathy” models so far
available are not very representative either. A main drawback
is the lack of nutrition in vitro, i.e., vascular supply, to provide
inflammatory cytokines and (immune) cells, which normally
FIGURE 7 | Advantages and disadvantages of tendinopathy models currently used. Adjusted from Reaction Biology Corp. (n.d.).
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regulate the in vivo repair process (Dirks and Warden, 2011;
Adekanmbi et al., 2017).
Scratch Models
A popular way to assess cell motility in 2D cultures is by a scratch
assay. A scratch defect can be created in confluent cell monolayers
with a sterile pipette microtip and can then be monitored for
several hours-days until closure of the scratch (Fessel et al., 2014).
This technique is most frequently used in wound healing studies
(Ranzato et al., 2009; Bussche et al., 2015; Liu et al., 2020), but can
also represent an acute tendon injury (Fessel et al., 2014; Randelli
et al., 2016; Adekanmbi et al., 2017). While in vivo all fibers are
disrupted, in the scratch model only a small defect is made in
the cell layers without the influence of ECM or fiber disturbance.
Another issue with this method is standardization, as the defect
is mostly applied manually and in contrast to the width of the
scratch, which is more fixed as one size of pipette tips is chosen
(e.g., a 2–200 µL pipet tip), trying to maintain a certain length
is much more variable (Liang et al., 2007). Other culture-inserts
[e.g., the Ibidi Culture-Inserts (Huang et al., 2019)] are available
to perform more reproducible experiments. However, when these
inserts are incorporated in a culture dish, cells grow separated
by a cell-free gap and are not disrupted after applying a scratch,
and as such, are less representative for tendon injury. Adekanmbi
et al. (2017) created a tendon scratch model by simulating a
tendon tear with a needle scratch on rat tail tendon fascicles to
study the effect of high frequency, low magnitude loading. They
standardized the scratch length with marker dots 1cm apart on
the petri dish (Adekanmbi et al., 2017). Finally, the scratch model
only represents an acute disruption, so no insights in chronic
tendinopathy mechanisms can be evaluated, and these assays are
usually performed in 2D models, lacking the complexity required
for a fundamental in vitro model.
Overstimulation
To mimic a tendinopathy and the accompanying inflammation
response in vitro, overstimulation can be realized by applying a
high mechanical load, a high stretch rate, or continuous cyclic
duration. As there is currently no consensus on the optimal
mechanical stimulation protocol for tendon homeostasis, it is
difficult to define what is “too much.” Different studies report
loading with excessive strain (>9%), which in vitro results
in integrity damage, cell apoptosis and increased collagen III
production (Legerlotz et al., 2013; Wang et al., 2013, 2017;
Zhang and Wang, 2013). Dudhia et al. (2007) on the other
hand, dissected the SDFT of horses of different ages to study
the effect of aging on matrix metalloproteinases activity in a
bioreactor with cyclic loading at 5% strain (1 Hz for 24 h).
They concluded that their cyclic loading protocol decreased
tendon tensile strength and function, and this effect was most
pronounced in the group containing the older horses (19 years
versus 3 years) (Dudhia et al., 2007). Wang et al. (2003) showed an
increase in prostaglandin E2 secretion, an inflammatory mediator
of tendinopathy, with increasing strain magnitude (4, 8, and 12%)
in human tenocytes cultures on micro-grooved silicone dishes
(Wang et al., 2003). Recently, Kubo et al. (2020) studied the short-
term influence of 5% cyclic uniaxial stretching with a frequency
of 1 or 2 Hz on primary tenocytes, cultured on PDMS chambers.
The 1 Hz group expressed significantly more collagen I and had
a higher cell proliferation compared to the 2 Hz or the non-
stretched control group. Moreover, the group stimulated with
2 Hz displayed several metabolic changes, such as significant
more cell apoptosis, reduced cell viability, and increased matrix
metalloproteinase secretion. Their findings contribute to the
identification of an appropriate overstimulation stretching profile
(Kubo et al., 2020).
Mimicking Inflammation
The actual impact of inflammatory processes on tendon disease
is controversial. Whilst the early inflammation phase is clearly
present in subacute injured tendons, persistent inflammation
results in fibrosis and impaired healing. Various studies have
evaluated supplementation with growth factors, cytokines, and
chemokines to mimic the acute inflammatory phase of tendon
injuries and to evaluate their effect on tenocytes, tendon
stem/progenitor cells, and tenogenic differentiation of MSCs.
An overview of all cells/inflammatory molecules involved in
tendon pathophysiology is beyond the scope of this review
and current insights have been recently reviewed elsewhere
(Tang et al., 2018; Chisari et al., 2020). Briefly, interleukin -
1β treatment reduced tenogenic gene expression of injured
tendon-derived stem/progenitor cells (scleraxis, tenomodulin,
collagen I, collagen III, biglycan and fibromodulin) and inhibited
adipogenic, chondrogenic, and osteogenic differentiation of
tendon stem/progenitor cells (Zhang et al., 2015). Stolk
et al. (2017) studied the response of human tenocytes on
pro-inflammatory factors and macrophages in an in vitro
inflammation model, and reported altered surface marker and
cytokine profiles. Furthermore, macrophage polarization was
influenced by the inflammatory environment (Stolk et al.,
2017). Alternatively, different immune cell populations can
also be introduced in an in vitro at different time points, as
these cells emerge depending on the stage of the disease. For
example, and while there are no macrophages present in normal
tendon tissue, pro-inflammatory M1 macrophages are observed
in subacute injured tendons, whereas immunosuppressive M2
macrophages are mainly observed with chronic tendinopathy
(Tang et al., 2018). Brandt et al. (2018) mimicked tendon
inflammation by adding interleukin-1β or tumor necrosis factor-
α, and evaluated the effect of peripheral blood leukocytes
on AT-MSCs differentiation. High cytokine concentrations
decreased ECM production and intracellular tenogenic gene
expression in both monoculture and static culture conditions
(co-cultures with leukocytes). More importantly, when dynamic
loading was incorporated in the co-cultures, a reduced effect
of the inflammation-mimicking cytokines was observed (Brandt
et al., 2018). As tendinopathy pathophysiology is not yet
completely understood and it is still unclear whether or
not the onset of inflammation is triggered by immune cells
or tenocytes, further research is mandatory to identify the
inflammatory components which should be introduced into
the disease model. In conclusion, a mixture of all the above-
mentioned injury-mimicking mechanisms should be evaluated
in 3D scaffolds.
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A STATE-OF-THE-ART IN VITRO
TENDINOPATHY MODEL
Based on the many requirements for a representative
physiological tendon and/or pathological tendinopathy model
in vitro, described throughout this review, it becomes clear
that in order to establish a state-of-the-art tendinopathy model
to improve knowledge on MSC-based tendon healing, an
appropriate biomaterial should be colonized with a relevant cell
source, combined with a pertinent production technology and
subsequently cultured in the most suitable bioreactor (Caddeo
et al., 2017). Mimicking the exact tendon pathophysiology
in vitro is mandatory to (i) make significant progress in our
understanding of tendinopathy mechanisms, (ii) unravel
MSC-associated tendon healing, (iii) evaluate novel, regenerative
treatments, and (iv) perform pharmacological experiments, while
reducing the number of animals used for biomedical research
purposes and related costs. The following requirements should be
fulfilled: (i) representative cellular growth as demonstrated by the
spindle-shape morphology and tenocyte marker expression, (ii)
production of ECM and cell–matrix interactions, (iii) supporting
nanometric and axially aligned structure (anisotropy), (iv)
responsive to physiological levels of uniaxial strain, (v) neuro-
vascular supply, and (vi) mimicking micro-damage like acute
injuries and chronic overuse (Figure 8).
Cells
The cells, relevant for the in vitro model, have to be capable
of colonizing the scaffold similar to native tissue. In tendon
tissue engineering, the most obvious cell type to utilize are
tenocytes, as they are the most abundant cell type in vivo (Tan
et al., 2015; Snedeker and Foolen, 2017; Wang et al., 2017;
Schneider et al., 2018). Tenocytes can be easily isolated from
adult tendons, but their unequivocal characterization is not
evident as there is no unique tendon marker yet. Morphological
characterization is usually performed, as tenocytes are spindle-
shape, nicely aligned cells (Tan et al., 2015). It is generally
FIGURE 8 | Requirements for the state-of-the-art tendinopathy model.
accepted to confirm the tenogenic identity by demonstrating
the presence of collagen I, collagen III, tenascin-C, scleraxis
and tenomodulin, either on gene or protein level (Schweitzer
et al., 2001; Zhu et al., 2010; Govoni et al., 2016; Wang et al.,
2017). Furthermore, dedifferentiation of the tenocytes should be
avoided by applying mechanical stimulation or other contact
guidance cues (Nikolovski et al., 2003; Park et al., 2006; Kuo et al.,
2010). Because adult cells have only a limited life span and have
usually a low proliferation rate (Caddeo et al., 2017), another
option is to use MSCs, which can be stimulated to differentiate
into a tenocyte-phenotype (Lake et al., 2020). Similar to the
in vivo situation, identifying the most appropriate cell source
is challenging. BM-MSCs are believed to be the most suitable
source to treat tendon injuries, but AT-MSCs or MSCs derived
from neonatal sources are present in higher numbers and more
easily accessible (Shojaee and Parham, 2019). Because tenogenic
differentiation is not as straightforward to achieve and various
stimulation parameters are involved, it is also possible to use
the intrinsic stem cell population present in the tendon, called
tendon stem/progenitor cells. These resident cells are responsible
for tendon maintenance and repair. Furthermore, these cells
are able to respond to inflammation following variable cytokine
signals and growth factor profiles. When abnormal pathway
activation occurs, tendon stem/progenitor cells differentiate into
inappropriate cell types such as chondrocytes or adipocytes,
resulting in calcification and metaplasia formation (Steinmann
et al., 2020). Unfortunately, tendon stem cells are difficult to
isolate because they are only present in small numbers in vivo
(Wu et al., 2018).
In the healing process, both the intrinsic and extrinsic
tendon cell populations, consisting of circulating cells and
cells from nearby tissues, play a role. Therefore, to study
the pathophysiological response in accordance to tendon
injury, immunocompetent cells should also be incorporated
in the model. Although the exact role of inflammatory and
immune cells remains unclear (Jomaa et al., 2020), these cells
are important for healing of the injured tendon (Caddeo
et al., 2017; Tang et al., 2018; Nichols et al., 2019; Jomaa
et al., 2020). Initial inflammation, accompanied by attraction
of macrophages and neutrophils is crucial for healing. Pro-
inflammatory M1 macrophages are mainly present during
this early stage, but prolonged activity is reported to result
in detrimental healing and increased scar tissue formation
(Tang et al., 2018; Nichols et al., 2019). M2 macrophages,
on the other hand, broadly described as anti-inflammatory,
contribute to ECM deposition and remodeling. However,
when inflammation and macrophage activity are completely
inhibited, decreased mechanical properties of the healed tissue
are observed. Nichols et al. (2019) reviewed the available research
on cell populations during tendon healing phases, and frequently
reported conflicting results. Therefore, inflammatory cell activity
should first be clarified and subsequently balanced cell activity
should be established in vitro to mimic the in vivo situation.
The interaction between resident cells (tenocytes, tendon stem
cells, or MSCs), immune cells, growth factors and cytokines
is crucial to gain new insights (Caddeo et al., 2017). These
immunomodulatory cells/molecules are in vivo partially provided
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through the blood stream, therefore incorporation of vascular
supply, or at least endothelial cells is mandatory (see section
“Neuro-Vascular Supply”) (Tempfer and Traweger, 2015).
Once the pathogenesis of tendinopathy is better understood,
supplementing appropriate inflammatory signals and cells to the
in vitro model to mimic the inflammation following injury, will
further improve our insights in MSC healing mechanisms. In
order to approximate the (patho-)physiological situation, one cell
type will not be sufficient, but a balanced mixture of all of the
above should be incorporated.
Extracellular Matrix (ECM)
As stated above, tendon ECM consists of collagen I and III, which
provides structure and mechanical strength. The proteoglycans
(e.g., decorin and lumican) are important in fibrillogenesis and
provide the tendon its high resistance to compressive and tensile
forces (viscoelasticity) (Tan et al., 2015; Schneider et al., 2018).
For an in vitro model, ECM should be included as it represents
80% of the in vivo tendon composition. Furthermore, cell–matrix
interactions should be enabled as ECM contains many different
growth factors, cytokines, and chemokines (Kleinman et al., 2003;
Buxboim et al., 2010). Simulating ECM using natural materials
is the most straightforward way to establish a representative
in vitro tendon model, but highly modified synthetic materials
(e.g., after adding integrin-binding peptide sequences) represent
a valuable alternative.
Supporting Nanometric Structure
There are three important matrix scales in tissue engineering: the
macroscopic shape (cm–mm level), the pore structure regulating
cell invasion and cell growth (µm level) and surface chemistry
which controls cell adhesion and gene expression (nm level)
(Kim and Mooney, 1998). For tendon tissue, this implies that
fiber diameters should be varying between 2 µm, i.e., diameter
of collagen fiber is 1–20 µm, and 200 µm, i.e., diameter of
fascicles (Figure 1) (Liu Y. et al., 2008). When murine fibroblasts
(C3H10T1/2) were cultured on fibers with larger diameter
(>2 µm), an increased tenogenic gene expression was observed
when compared to small (<1 µm) and medium fiber diameters
(1–2 µm) (Cardwell et al., 2014). The maximum fiber diameter
is mainly limited by oxygen diffusion capacity (max. 200 µm).
In vivo, fascicles are surrounded by endotenon (Figure 1), which
includes blood vessels providing nutrients and oxygen, and thus,
the designed in vitro scaffolds also need to support nutrients
and oxygen supply (Kim and Mooney, 1998; Lu et al., 2013).
Furthermore, pore size is also critical, as it allows cell infiltration,
nutrition, proliferation and migration (Sensini and Cristofolini,
2018; Luo, 2020). Besides superior cell characteristics, increased
and interconnected porosity (usually >90%) also facilitates
efficient nutrient and oxygen diffusion and waste removal (Loh
and Choong, 2013). The lower limit of pore size is determined
by cell size (±20 µm) whereas the upper limit is depending on
biomaterial and cell combination (100–200 µm) (Freyman et al.,
2001). However, the disadvantage of high porosity is the fact that
mechanical properties are compromised due to the large amount
of dead volume (Loh and Choong, 2013).
Because of the axially aligned nature of collagen fibrils in vivo,
a tendon model should provide parallelly aligned fibers (Cardwell
et al., 2014) to provide tensile strength during loading and
cell proliferation stimuli (Kleinman et al., 2003; Dudhia et al.,
2007). The microstructural anisotropy might even influence gene
expression levels without modifying gene sequence (epigenetic
role) (Wang et al., 2018). Therefore, an in vitro tendinopathy




The hierarchical anisotropic tendon structure typically enables
its non-linear mechanical properties (Sensini and Cristofolini,
2018). When tendons are subjected to mechanical load, the
collagen fibers stretch out, nullifying the unique crimp-pattern
(called “toe region”). When the mechanical load is increased
further, collagen molecules become more aligned, resulting
initially in linear stretching, followed by microscopic damage
and finally macroscopic tearing (Wang, 2006; Sensini and
Cristofolini, 2018). The slope of the stress-strain curve represents
the tendon stiffness, also known as Young’s modulus. The linear
phase of this curve in human tendons is quite short (2–6%)
and similar for each tendon of the human body (Figure 9).
The loading response of the equine SDFT results in a similar
stress-strain curve with linear deformation between 3.6 and
10% (examined on an adult fore limb SDFT in vitro) which
supports the claim for the equine SDFT as a model for human
Achilles tendinopathy (Figure 9) (Patterson-Kane et al., 2012;
Sensini and Cristofolini, 2018). Mechanical properties, however,
are dependent on tendon cross-section and function (Sensini and
Cristofolini, 2018). As the aim of the in vitro model is to generate
a physiological response, the cultured cells should experience
scaffold stiffness and strain comparable to the in vivo situation,
resulting in similar cell behavior (Patterson-Kane et al., 2012).
As musculoskeletal loading is essential for maintaining tendon
homeostasis, cyclic strain should be included in culture systems
(Patterson-Kane et al., 2012). While subtle changes in mechanical
loading result in an anabolic and anti-inflammatory response,
both over- and under-stimulation can result in degeneration and
remodeling of the ECM (Patterson-Kane et al., 2012; Wang et al.,
2013; Youngstrom and Barrett, 2016). As already mentioned, it
is challenging to identify a suitable protocol to mimic the in vivo
load of tendon. Indeed, the tendon response to mechanical load
is varying depending on the location in the body, the age of
the human or animal, and the differentiation level of the cells
(Patterson-Kane et al., 2012). In conclusion, mechanical loading
should be within physiological range, i.e., (Achilles tendon: 2–6%,
SDFT: 3–10%, Figure 9) in the context of translational research.
Neuro-Vascular Supply
In vivo, tendon is considered as a hypovascular tissue as blood
supply is only present in the endo- and epitenon (Evans, 2012;
Docheva et al., 2015; Tempfer and Traweger, 2015; Schneider
et al., 2018; Sensini and Cristofolini, 2018; Costa-Almeida
et al., 2019). Nevertheless, also in tendon, cells, growth factors
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FIGURE 9 | (A) Stress-strain curve of the human Achilles tendon. (B) Stress-strain curve of the equine superficial digital flexor tendon. Stress: applied force over
area, Strain: deformation in response to stretch, Elasticity: stress/strain ratio or how force results in a deformation of the tissue. Adjusted from Barfod (2014).
and cytokines should be delivered through the blood stream,
besides nutrients and oxygen. Increased vascularization and scar
tissue formation is observed with tendon injuries (Tempfer
and Traweger, 2015). Therefore, vascularization should also be
incorporated in an in vitro tendinopathy model which remains a
major challenge in tissue engineering. 3D bioprinting, however,
could offer a solution. As proposed by Richards et al. (2016),
a mixture of tissue-specific and pro-vascular bioink should be
printed with tenocytes and endothelial cells in exact spatial
distribution. Wu et al. (2017) showed that the expression of
tenogenic markers was upregulated when AT-MSCs, tenocytes,
and HUVECS, were cultured together, illustrating that tenocytes
also profit from providing vascularization.
Besides blood vessels, the endo- and epitenon contain nerves
and lymphatic vessels to support the tendon cells in their
function (Wang, 2006; Docheva et al., 2015; Tan et al., 2015;
Schneider et al., 2018). During tendon inflammation, different
neuronal mediators play an active role in regulating pain and
the inflammation process (Ackermann, 2013; Tempfer and
Traweger, 2015). However, the exact mechanisms are not yet
elucidated. The incorporation of (induced) pluripotent stem cells
capable of neural differentiation and MSCs or adult neural stem
cells, in an in vitro model is of great importance (Maltman et al.,
2011; Azari and Reynolds, 2016; Snedeker and Foolen, 2017),
but is still in its infancy for both tendon and other types of
tissue engineering.
Microdamage Leading to Failure
It is generally accepted that tendinopathy occurs due to chronic
overuse. As a reaction to the matrix disruption, in vivo
neovascularisation is observed. VEGF is highly secreted which
results in increased matrix metalloproteinase secretion and
further matrix degradation (Tempfer and Traweger, 2015).
Petersen et al. (2004) demonstrated increased VEGF secretion
in response to 1 Hz cyclic stretching and decreased expression if
low frequency is used (0.5 Hz). As discussed above, by subjecting
strain above physiological level, one should be able to create
a tendinopathy model (Wang et al., 2003, 2013). The exact
protocol should be defined as different responses will be observed
depending on the (bio-)material of choice. Incorporation of
inflammatory molecules and cells will represent the detrimental
environment after the ideal mechanical protocol is defined.
CONCLUSION
After decades of research, it is clear that MSC-derived bioactive
factors have great regenerative potential in healing tendon
injuries. Yet, clinical application remains limited due to the
unclarified pathogenesis of tendinopathy and MSCs’ underlying
mechanisms of action. The complexity of in vitro tendon
engineering has been evolving the last decade, and substantial
progress has been made in mimicking tendon physiology by
switching from 2D tenocyte cultures to 3D jet writing. The
appropriate biomaterials, bioreactor and production technology
should be combined to create in vitro tendon (Govoni et al.,
2016). However, currently used models are far from ideal,
especially by the functional (neuro-)vascular supply which is
still lacking (Richards et al., 2016). The major remark in all
listed models is the lack of consistency. All research groups
developed and used their own protocols, mono-materials and
hybrids, making conclusions impossible and preventing scientific
progress. Moreover, both natural and synthetic materials are
used interchangeably, in different combinations, and in different
proportions. A crucial step to success is identifying the optimal
mix of materials, manufacturing techniques, and biological
stimuli, to mimic representative tendon properties. To achieve
this, a multidisciplinary approach is needed where experts
in biotechnology, cell biology, molecular biology, material
sciences, physics, physiology, bioengineering and polymer
chemistry join forces (Siemionow, 2015; Aibibu et al., 2016).
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We propose future models need to incorporate collagen
or gelatin simulating the tendon ECM, either chemically
modified or reinforced with a strong synthetic material, such
as PCL, to mimic the cellular microenvironment (ECM,
mechanical characteristics, . . .). As cell encapsulation is the
most representative technique, resident cells (tenocytes, tendon
stem cells, or MSCs), immune cells, growth factors and
cytokines should be incorporated in a biomaterial-cell mixture
for 3D-bioprinting. Applying mechanical stimulation in a
stretch-perfusion bioreactor, once the appropriate strains have
been identified, will enable to representatively mimic the
tendon environment in both physiological and pathological
conditions. In addition, vascularization should be present
either by medium perfusion or by incorporating endothelial
cells. A representative pathophysiological tendon model can
be established by combining mild overstimulation for a
longer period of time (e.g., 3 weeks), mimicking the chronic
situation, and an acute extreme overloading and/or scratch,
representing the acute injury. It is only a matter of time
until tendon pathophysiology is unraveled as tendon tissue
engineering strategies are rapidly evolving. Therefore, in vitro
models can provide strategies to solve the MSC puzzle
and evidence-based treatment protocols can be established
which will quickly become available to tendinopathy patients,
irrespective of the species.
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